Nano Labs (NA) updates Form F-3 shelf registrations with new 6-K exhibits

Rhea-AI Filing Summary

Nano Labs Ltd furnished a Form 6-K as a foreign private issuer, providing additional information to U.S. investors. The company states that the document attached as Exhibit 99.1 is incorporated by reference into its existing shelf registration statements on Form F-3, one initially filed on August 14, 2023 and another initially filed on August 4, 2025, so that this material becomes part of those offerings unless later superseded. The filing also lists a press release as Exhibit 99.1 and a sales agreement as Exhibit 99.2, indicating these materials are now formally on record with U.S. regulators.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

Commission File Number: 001-41426

Nano Labs Ltd

(Exact name of registrant as specified in its charter)

China Yuangu Hanggang Technology Building

509 Qianjiang Road, Shangcheng District,

Hangzhou, Zhejiang, 310000

People’s Republic of China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒         Form 40-F ☐

EXPLANATORY NOTE

The document attached as Exhibit 99.1 to this report on Form 6-K is hereby incorporated by reference into the Company’s Registration Statement on Form F-3, as amended, initially filed with the U.S. Securities and Exchange Commission on August 14, 2023 (Registration No. 333-273968) and the Company's Registration Statement on Form F-3, as amended, initially filed with the U.S. Securities and Exchange Commission on August 4, 2025 (Registration No. 333-289211) and shall be a part thereof from the date on which this current report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: August 21, 2025	Nano Labs Ltd
	By:	/s/ Jianping Kong
	Name:	Jianping Kong
	Title:	Chairman and Chief Executive Officer

2

EXHIBIT INDEX

Exhibit No.		Description
99.1		Press Release
99.2		Sales Agreement

3

FAQ

What does Nano Labs Ltd (NA) report in this Form 6-K?

Nano Labs Ltd reports that a document filed as Exhibit 99.1 to this Form 6-K is being incorporated by reference into its two existing Form F-3 registration statements, making that material part of those shelf offerings unless later superseded.

How does this Form 6-K affect Nano Labs Ltd’s Form F-3 registrations?

The company states that Exhibit 99.1 is incorporated by reference into its Form F-3 registration statement initially filed on August 14, 2023 and its Form F-3 registration statement initially filed on August 4, 2025, so those registration statements now include the contents of Exhibit 99.1.

What exhibits are included in Nano Labs Ltd’s August 2025 Form 6-K?

The exhibit index lists two items: Exhibit 99.1 described as a press release, and Exhibit 99.2 described as a sales agreement.

Who signed the Form 6-K for Nano Labs Ltd (NA)?

The report was signed on behalf of Nano Labs Ltd by Jianping Kong, identified as the company’s Chairman and Chief Executive Officer.

Does this Form 6-K disclose a new sales agreement for Nano Labs Ltd?

The filing identifies a document described as a Sales Agreement as Exhibit 99.2. The detailed terms of that agreement are contained in the exhibit itself, which is listed but not described further in the main text.